Non-lethal congenital hypotonia due to glycogen storage disease type IV
- PMID: 16528737
- DOI: 10.1002/ajmg.a.31166
Non-lethal congenital hypotonia due to glycogen storage disease type IV
Abstract
Glycogen storage disease type IV (GSD-IV) is an autosomal recessive genetic disorder due to a deficiency in the activity of the glycogen branching enzyme (GBE). A deficiency in GBE activity results in the accumulation of glycogen with fewer branching points and long, unbranched outer chains. The disorder results in a variable phenotype, including musculoskeletal, cardiac, neurological, and hepatic involvement, alone or in continuum, which can be identified at any stage of life. The classic form of GSD-IV is a hepatic presentation, which presents in the first 18 months of life with failure to thrive, hepatomegaly, and cirrhosis that progresses to liver failure, resulting in death by age 5 years. A severe congenital musculoskeletal phenotype with death in the neonatal period has also been described. We report an unusual case of congenital musculoskeletal presentation of GSD-IV with stable congenital hypotonia, gross motor delay, and severe fibro-fatty replacement of the musculature, but no hepatic or cardiac involvement. Molecular analysis revealed two novel missense mutations with amino acid changes in the GBE gene (Q236H and R262C), which may account for the mild phenotype.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene.J Clin Invest. 1996 Feb 15;97(4):941-8. doi: 10.1172/JCI118517. J Clin Invest. 1996. PMID: 8613547 Free PMC article.
-
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV).Neurology. 2004 Sep 28;63(6):1053-8. doi: 10.1212/01.wnl.0000138429.11433.0d. Neurology. 2004. PMID: 15452297
-
Branching enzyme deficiency/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: muscle biopsy and autopsy findings, biochemical and molecular genetic studies.Neuromuscul Disord. 2010 Dec;20(12):783-90. doi: 10.1016/j.nmd.2010.07.275. Epub 2010 Sep 15. Neuromuscul Disord. 2010. PMID: 20833045
-
The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies.Curr Mol Med. 2002 Mar;2(2):177-88. doi: 10.2174/1566524024605815. Curr Mol Med. 2002. PMID: 11949934 Review.
-
Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review.Hum Pathol. 2012 Jun;43(6):943-51. doi: 10.1016/j.humpath.2011.10.001. Epub 2012 Feb 2. Hum Pathol. 2012. PMID: 22305237 Review.
Cited by
-
Glycogen Storage Disease Type IV: A Rare Cause for Neuromuscular Disorders or Often Missed?JIMD Rep. 2019;45:99-104. doi: 10.1007/8904_2018_148. Epub 2018 Dec 20. JIMD Rep. 2019. PMID: 30569318 Free PMC article.
-
Case of Neonatal Fatality from Neuromuscular Variant of Glycogen Storage Disease Type IV.JIMD Rep. 2019;45:51-55. doi: 10.1007/8904_2018_142. Epub 2018 Oct 12. JIMD Rep. 2019. PMID: 30311141 Free PMC article.
-
Glycogen metabolism and glycogen storage disorders.Ann Transl Med. 2018 Dec;6(24):474. doi: 10.21037/atm.2018.10.59. Ann Transl Med. 2018. PMID: 30740405 Free PMC article. Review.
-
A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum.Front Genet. 2022 Sep 13;13:992406. doi: 10.3389/fgene.2022.992406. eCollection 2022. Front Genet. 2022. PMID: 36176296 Free PMC article.
-
Neuromuscular forms of glycogen branching enzyme deficiency.Acta Myol. 2007 Jul;26(1):75-8. Acta Myol. 2007. PMID: 17915577 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
